Keosys Medical Imaging

AUGUST 26, 2024

With her large experience in the pharmaceutical industry, Helen Blanco currently serves as Chief Operating Officer at Node Pharma , a preclinical radiopharmaceutical company based in Norway. We recently spoke with Helen about the key criteria when selecting an imaging vendor and exciting upcoming innovations in the oncology space.

Pharmaceutical 98

Pharmaceutical Radiopharmaceuticals Imaging Medical Imaging 98

Open Medscience

OCTOBER 1, 2024

Good Manufacturing Practices ensure the consistent quality, safety, and efficacy of pharmaceutical products through rigorous production standards. The post Overview of Good Manufacturing Practices (GMP) in Radiopharmaceuticals appeared first on Open MedScience.

Radiopharmaceuticals 52

Radiopharmaceuticals Pharmaceutical 52

Imaging Technology

JULY 11, 2023

By leveraging our expertise in radiopharmaceuticals, we aim to contribute to the early detection and accurate monitoring of epithelial-derived cancers. This further strengthens our commitment to production and development of novel radiopharmaceuticals to advance cancer treatments and quality of life for cancer patients."

Radiopharmaceuticals 75

Radiopharmaceuticals Imaging Pharmaceutical Disease 75

AuntMinnie

OCTOBER 17, 2023

Blue Earth Diagnostics and Sinotau Pharmaceutical have signed an agreement to distribute Blue Earth's Posluma (flotufolastat F-18) PET radiotracer in China.

Pharmaceutical 52

Pharmaceutical Diagnostic Radiopharmaceuticals 52

AuntMinnie

MAY 1, 2024

Food and Drug Administration (FDA) has approved Novartis' Lutathera (lutetium-177 [Lu-177]) DOTATATE radiopharmaceutical for treatment of pediatric patients who are 12 years old and older with somatostatin receptor (SSTR)-positive gastroentropancreatic neuroendocrine tumors (GEP-NETs).

Radiopharmaceuticals 96

Radiopharmaceuticals Pharmaceutical Radiology 96

Imaging Technology

APRIL 13, 2023

He has more than 22 years of operational and commercial expertise in radioisotopes and radiopharmaceuticals. actinium-225 (Ac-225), and drive business development initiatives for NorthStar’s Radiopharmaceutical CDMO/CMO business units. Ac-225 and Cu-67 using environmentally preferable technologies. SPECT franchise.

Radiopharmaceuticals 97

Radiopharmaceuticals Medical Pharmaceutical Nuclear Medicine 97

Imaging Technology

JUNE 19, 2023

milla1cf Mon, 06/19/2023 - 19:27 June 19, 2023 — NorthStar Medical Technologies, LLC , a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Frank Scholz, Ph.D., NorthStar’s commercialized, U.S.-based

Medical 98

Medical Pharmaceutical Radiopharmaceuticals Nuclear Medicine 98

Imaging Technology

JULY 25, 2024

BWXT Medical will collaborate closely with NorthStar, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, to streamline production processes, enhance safety protocols and innovate new methods of isotope generation.

Medical 105

Medical Radiopharmaceuticals Pharmaceutical Clinic 105

Imaging Technology

APRIL 24, 2023

milla1cf Mon, 04/24/2023 - 14:10 April 24, 2023 — - NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, has announced the appointment of Jean-Noel David , MBA, MS, as Vice President, Operations.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Government 98

Imaging Technology

JULY 9, 2024

Marco Campione brings more than 25 years of experience from GE HealthCare, where he most recently served as Executive Director and Global Head of Contrast Media, General Manager Pharmaceutical Diagnostics North America and President GE HealthCare Inc., Campione also joins the Blue Earth Diagnostics Ltd. Bracco Imaging S.p.A.,

Diagnostic 105

Diagnostic Radiopharmaceuticals Nuclear Medicine Magnetic Resonance Imaging 105

Open Medscience

OCTOBER 1, 2024

ICH Q10 is a global model for managing pharmaceutical quality, ensuring compliance, continuous improvement, and risk manage The post The International Council for Harmonization (ICH) Q10: A Model for a Robust Pharmaceutical Quality Management System appeared first on Open MedScience.

Pharmaceutical 52

Pharmaceutical Quality and Compliance Risk Management Radiopharmaceuticals 52

Imaging Technology

FEBRUARY 14, 2024

PanTera is committed to supporting the pharmaceutical industry by scaling up production to meet the significant global demand for targeted radiopharma-based therapeutics in the fight against cancer.”

Pharmaceutical 105

Pharmaceutical Radiopharmaceuticals Medical Clinic 105

AuntMinnie

FEBRUARY 16, 2024

Fusion Pharmaceuticals announced a patent dispute settlement and new licensing agreement with Heidelberg University and Euratom for exclusive, worldwide rights to their existing patent for FPI-2265, an actinium-225-based targeted radiotherapy for the treatment of prostate-specific membrane antigen (PSMA)-expressing cancers.

Pharmaceutical 40

Pharmaceutical Radiopharmaceuticals Medical IT 40

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

Imaging Technology

JULY 5, 2023

Nucleus will use NorthStar’s Ac-225 for their customers’ radioligand pharmaceutical programs. Ac-225 and copper-67 (Cu-67) for advancing clinical research and commercial radiopharmaceutical therapy products. Ac-225 to Nucleus. The Company will use its electron accelerator technology to produce n.c.a.

Medical 92

Medical Radiopharmaceuticals Pharmaceutical Radiation 92

AuntMinnie

JUNE 26, 2023

facility NorthStar produces first Mo-99 batch at new facility NorthStar and Inhibrx ink deal on radiopharmaceutical development NorthStar completes construction of Mo-99 production facility Read more on AuntMinnie.com Related Reading: NorthStar appoints new president/CEO NorthStar installs accelerator at its new Wisc.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Medical IT 52

Imaging Technology

AUGUST 31, 2023

milla1cf Thu, 08/31/2023 - 15:50 August 31, 2023 — NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals, and Curadh MTR Inc. Ac-225 for use in radiopharmaceutical therapy (RPT). actinium-225 (Ac-225). “As a company at the forefront of U.S.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

Imaging Technology

OCTOBER 11, 2023

As a standalone company, we are keen to collaborate with companies like SOFIE in this way – bringing our size, scale and unique perspective as a developer, of both radiopharmaceuticals and the scanners needed to utilize them, to drive innovation in healthcare to benefit patients and clinicians.” Sherly Mosessian , Ph.D, Sherly Mosessian , Ph.D,

Healthcare 105

Healthcare Healthcare Pharmaceutical Radiopharmaceuticals 105

AuntMinnie

JULY 12, 2024

Reshaping the hospital's nuclear medicine and radiopharmaceutical strategy toward theranostics involves intensive and inclusive planning, Beyder explained at SNMMI. Centers for Medicare and Medicaid (CMS) and manufacturers that agree to provide pharmaceuticals at significantly reduced rates for facilities that qualify.

Nuclear Medicine 105

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 105

Imaging Technology

NOVEMBER 26, 2023

TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical research organizations (CROs) and pharmaceutical manufacturers. Radiopharmaceuticals are revolutionizing modern cancer treatment and precision dosimetry is a crucial component of this advanced therapy.

Clinic 78

Clinic Radiopharmaceuticals Radiosensitivity Pharmaceutical 78

Imaging Technology

AUGUST 28, 2023

This volume would be equivalent to 50% of today’s supply and would underpin the wider development of these targeted alpha therapy radiopharmaceuticals as an effective treatment modality for cancer", commented Sven Van den Berghe, PanTera’s Chief Executive Officer.

Radiopharmaceuticals 98

Radiopharmaceuticals Pharmaceutical Medical Clinic 98

AuntMinnie

JULY 24, 2023

Radiopharmaceutical developer Clarity Pharmaceuticals has reached 50% recruitmen.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

JUNE 23, 2023

Radiopharmaceutical developer Actinium Pharmaceuticals is highlighting six researc. Read more on AuntMinnie.com Related Reading: Actinium, Astellas to create actinium-225 radiotherapies Zevacor signs on as manufacturing partner for Actinium

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

JANUARY 24, 2024

TerraPower Isotopes has shipped its first samples of Actinium-225 (Ac-225) to two pharmaceutical companies to develop targeted cancer treatments in drug trials. Global demand for Ac-225 is expected to increase as more radiopharmaceutical treatments using Actinium-225 are developed, the company noted.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Radiation Oncology IT 52

AuntMinnie

OCTOBER 22, 2024

NorthStar Medical Radioisotopes has launched its new radiopharmaceutical Contract Development and Manufacturing (CDMO) facility on its campus in Beloit, WI.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Medical IT 52

AuntMinnie

AUGUST 22, 2024

Food and Drug Administration (FDA) has granted Clarity Pharmaceuticals fast-track designation for its copper-64 (Cu-64) sarcophagine (SAR) bisPSMA radiopharmaceutical.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Disease Clinic 52

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

AuntMinnie

AUGUST 10, 2023

Radiopharmaceutical developer Clarity Pharmaceuticals is highlighting the completio.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

JULY 19, 2023

Read more on AuntMinnie.com Related Reading: NorthStar manufactures Cu-67 for Clarity Pharmaceuticals NorthStar appoints new president/CEO NorthStar installs accelerator at its new Wisc. facility NorthStar produces first Mo-99 batch at new facility NorthStar and Inhibrx ink deal on radiopharmaceutical development

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Medical IT 52

AuntMinnie

SEPTEMBER 11, 2023

Turkish radiopharmaceutical company Eczacıbaşı-Monrol plans t.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

OCTOBER 22, 2024

Telix Pharmaceuticals plans to spin off its wholly-owned subsidiary Rhine Pharma and structure it as an independent company. Rhine Pharma’s mission will be to expand global access to radiopharmaceuticals for cancer imaging and treatment using two generator-produced isotopes, technetium-99m (Tc-99m) and rhenium-188 (Re-188), the company said.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Hospital Clinic 52

AuntMinnie

NOVEMBER 20, 2024

Telix Pharmaceuticals is expanding its theranostic pipeline with newly acquired assets targeting fibroblast activation protein (FAP) in nuclear medicine.

Nuclear Medicine 52

Nuclear Medicine Pharmaceutical Radiopharmaceuticals Clinic 52

AuntMinnie

JANUARY 5, 2024

Lu-177 is a medical radioisotope frequently used in radiopharmaceutical therapy to treat cancer. This is a mandatory process needed to obtain pharmaceutical manufacturing authorization. ITM said with the RAM license and other regulatory approvals, the company has achieved operational readiness.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Medical 52

AuntMinnie

SEPTEMBER 22, 2024

Telix Pharmaceuticals has inked a deal to acquire Florida-based radiopharmacy network RLS Radiopharmacies for up to $250 million, the companies announced. and distributes PET, SPECT, and therapeutic radiopharmaceuticals through 31 radiopharmacies across 18 states, Telix said. “By

Radiopharmaceuticals 52

Radiopharmaceuticals Pharmaceutical Diagnostic IT 52

AuntMinnie

OCTOBER 25, 2023

Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, and PSI CRO, a global contract research organization, plan to conduct a trial using Clarity's phase III diagnostic trial of Clarify for prostate cancer patients.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Diagnostic Clinic 52

AuntMinnie

JUNE 10, 2024

Evans, a professor in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco, was recognized for his work in biomarker discovery and radiopharmaceutical development. He has published more than 90 peer-reviewed articles and is a co-inventor on 13 patents pending or issued.

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Pharmaceutical Clinic 40